| Primary |
| Drug Use For Unknown Indication |
46.9% |
| Stent Placement |
11.4% |
| Hypertension |
5.9% |
| Acute Coronary Syndrome |
3.7% |
| Myocardial Infarction |
3.7% |
| Prophylaxis |
3.7% |
| Transient Ischaemic Attack |
3.7% |
| Suicide Attempt |
2.9% |
| Cerebrovascular Accident |
2.6% |
| Agitation |
2.2% |
| Antiplatelet Therapy |
2.2% |
| Diabetes Mellitus |
1.8% |
| Coronary Artery Disease |
1.5% |
| Oedema |
1.5% |
| Aortic Valve Replacement |
1.1% |
| Atrial Fibrillation |
1.1% |
| Coronary Angioplasty |
1.1% |
| Encephalopathy |
1.1% |
| Product Used For Unknown Indication |
1.1% |
| Type Ii Diabetes Mellitus |
1.1% |
|
| Thrombosis In Device |
11.1% |
| Leukopenia |
8.9% |
| Pulmonary Fibrosis |
8.9% |
| Gastric Ulcer |
6.7% |
| Vascular Occlusion |
6.7% |
| Atrial Fibrillation |
4.4% |
| Cerebrovascular Accident |
4.4% |
| Confusional State |
4.4% |
| Pancytopenia |
4.4% |
| Rhabdomyolysis |
4.4% |
| Skin Exfoliation |
4.4% |
| Somnolence |
4.4% |
| Stevens-johnson Syndrome |
4.4% |
| Thrombosis |
4.4% |
| Ventricular Extrasystoles |
4.4% |
| Weight Decreased |
4.4% |
| Amnesia |
2.2% |
| Aortic Aneurysm Rupture |
2.2% |
| Aplasia Pure Red Cell |
2.2% |
| Condition Aggravated |
2.2% |
|
| Secondary |
| Hypertension |
17.4% |
| Drug Use For Unknown Indication |
14.7% |
| Diabetes Mellitus |
9.3% |
| Coronary Artery Disease |
6.3% |
| Cerebral Haemorrhage |
5.7% |
| Myocardial Infarction |
5.7% |
| Stent Placement |
5.2% |
| Sleep Disorder |
3.8% |
| Depression |
3.4% |
| Muscle Spasticity |
3.4% |
| Platelet Aggregation |
3.4% |
| Thrombosis Prophylaxis |
3.4% |
| Pain |
2.9% |
| Hypokalaemia |
2.7% |
| Prophylaxis |
2.5% |
| Hyperthyroidism |
2.3% |
| Polyuria |
2.3% |
| Hyperlipidaemia |
2.0% |
| Agitation |
1.8% |
| Coronary Angioplasty |
1.8% |
|
| Gastric Ulcer |
21.4% |
| Thrombosis In Device |
10.0% |
| Pancytopenia |
7.1% |
| Haemorrhoidal Haemorrhage |
5.7% |
| Swollen Tongue |
5.7% |
| Gastrointestinal Haemorrhage |
4.3% |
| Hepatitis |
4.3% |
| In-stent Arterial Restenosis |
4.3% |
| Oesophagitis Haemorrhagic |
4.3% |
| Ventricular Flutter |
4.3% |
| Cerebrovascular Accident |
2.9% |
| Confusional State |
2.9% |
| Gastrointestinal Ulcer Haemorrhage |
2.9% |
| Pulmonary Fibrosis |
2.9% |
| Retinal Vein Thrombosis |
2.9% |
| Rhabdomyolysis |
2.9% |
| Syncope |
2.9% |
| Thrombosis |
2.9% |
| Type 1 Diabetes Mellitus |
2.9% |
| Ventricular Arrhythmia |
2.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.6% |
| Hypertension |
19.0% |
| Product Used For Unknown Indication |
14.9% |
| Coronary Artery Disease |
5.6% |
| Prophylaxis Of Nausea And Vomiting |
4.5% |
| Rheumatoid Arthritis |
4.3% |
| Type 2 Diabetes Mellitus |
3.4% |
| Pain |
2.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
| Urinary Tract Infection |
2.7% |
| Hyperparathyroidism Secondary |
2.6% |
| Prophylaxis |
2.4% |
| Depression |
2.3% |
| Diabetes Mellitus |
2.3% |
| Hyperlipidaemia |
2.3% |
| Osteoporosis |
2.0% |
| Atrial Fibrillation |
1.8% |
| Ischaemic Heart Disease Prophylaxis |
1.6% |
| Myocardial Infarction |
1.5% |
| Hyperuricaemia |
1.5% |
|
| Myocardial Infarction |
9.6% |
| Faecaloma |
7.0% |
| Progressive Multifocal Leukoencephalopathy |
7.0% |
| Hyponatraemia |
6.1% |
| Syncope |
6.1% |
| Transplant Failure |
6.1% |
| Somnolence |
5.3% |
| Staphylococcal Bacteraemia |
5.3% |
| Vomiting |
5.3% |
| Clostridium Difficile Colitis |
4.4% |
| Hypophagia |
4.4% |
| Nausea |
4.4% |
| Paralysis |
4.4% |
| Atrial Fibrillation |
3.5% |
| Gastrointestinal Ulcer Haemorrhage |
3.5% |
| Hypertension |
3.5% |
| Hypertensive Crisis |
3.5% |
| Hypokalaemia |
3.5% |
| Rash Maculo-papular |
3.5% |
| Renal Failure Acute |
3.5% |
|
| Interacting |
| Coronary Artery Disease |
14.7% |
| Hypertension |
13.5% |
| Encephalopathy |
8.8% |
| Diabetes Mellitus |
8.2% |
| Leukoencephalopathy |
8.2% |
| Aphasia |
5.9% |
| Hashimoto's Encephalopathy |
5.3% |
| Reflux Oesophagitis |
4.7% |
| Osteoporosis Prophylaxis |
4.1% |
| Renal Failure Chronic |
3.5% |
| Atrial Fibrillation |
2.9% |
| Carotid Artery Stenosis |
2.9% |
| Convulsion |
2.9% |
| Transient Ischaemic Attack |
2.9% |
| Colitis Ulcerative |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Dyslipidaemia |
2.4% |
| Angina Pectoris |
1.8% |
| Cardiovascular Event Prophylaxis |
1.2% |
| Hyperlipidaemia |
1.2% |
|
| Pancytopenia |
30.4% |
| Drug Interaction |
21.7% |
| Pyrexia |
13.0% |
| Hepatocellular Injury |
8.7% |
| Haemorrhagic Anaemia |
4.3% |
| Neoplasm |
4.3% |
| Oesophagitis Haemorrhagic |
4.3% |
| Paraesthesia |
4.3% |
| Paraplegia |
4.3% |
| Upper Gastrointestinal Haemorrhage |
4.3% |
|
